Send InquiryPalbociclib intermediates,5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine 733039-20-8
Product Code : 733039-20-8
Brand Name : DM
Price And Quantity
- Minimum Order Quantity
- 1g Gram
- Price Range
- 10.00 - 20.00 USD ($)
Product Specifications
- Structural Formula
- C9H11BrClN3
- Smell
- No Smell
- Storage
- Room Temperature
- HS Code
- 29339900
- Molecular Formula
- C9H11BrClN3
- Boiling point
- 424℃ at 760mmHg
- Molecular Weight
- 276.56074 Milligram (mg)
- Taste
- Odorless
- Melting Point
- 424℃ at 760mmHg
- Shelf Life
- 2 Years
- Medicine Name
- Palbociclib intermediates
- Chemical Name
- 5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine
- CAS No
- 733039-20-8
- Type
- Pharmaceutical Intermediates
- Grade
- Medicine Grade
- Usage
- Palbociclib intermediates
- Purity(%)
- 99
- Appearance
- white powder
- Physical Form
- Powder
Product Description
| Physical Properties | |||
| Appearance | White crystalline powder | Purity | 99% |
| Molecular formula | C9H11BrClN3 | Molecular weight | 276.56074 |
| Boiling point | 424 at 760mmHg | Flashing point | 210.2 |
Trade Information
- FOB Port
- any port in China
- Payment Terms
- Cash Against Delivery (CAD), Cash in Advance (CID), Days after Acceptance (DA), Letter of Credit at Sight (Sight L/C), Paypal
- Supply Ability
- 100kgs Per Month
- Delivery Time
- 1 Week
- Sample Policy
- Within a certain price range free samples are available
- Packaging Details
- as per request
- Main Export Market(s)
- Asia, Central America, North America, South America, Western Europe, Africa
- Main Domestic Market
- All India
- Certifications
- ISO9001
X
Get in touch with us
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTD.
- B No.52 Zhaiying South street,Yuhua Dostrict, Shijiazhuang - 050000, Hebei, China
- Ms. Lily (General Manager)
- Send Inquiry
Send Inquiry
Send InquirySHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
